Macedonia (the former Yugoslav Republic of)

Macedonia (the former Yugoslav Republic of)

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0.81 (0.70 - 0.91) 2019 Modelled IHME
0.83 (0.72 - 0.94) 2018 Modelled IHME
0.85 (0.73 - 0.97) 2017 Modelled IHME
0.85 (0.73 - 0.96) 2016 Modelled IHME
0.85 (0.73 - 0.98) 2015 Modelled IHME
0.86 (0.73 - 0.98) 2014 Modelled IHME
0.86 (0.74 - 0.98) 2013 Modelled IHME
0.88 (0.75 - 0.99) 2012 Modelled IHME
0.89 (0.75 - 1.01) 2011 Modelled IHME
0.9 (0.76 - 1.03) 2010 Modelled IHME
0.91 (0.77 - 1.04) 2009 Modelled IHME
0.93 (0.78 - 1.06) 2008 Modelled IHME
0.95 (0.80 - 1.08) 2007 Modelled IHME
0.96 (0.82 - 1.10) 2006 Modelled IHME
0.97 (0.82 - 1.11) 2005 Modelled IHME
0.97 (0.83 - 1.11) 2004 Modelled IHME
0.98 (0.84 - 1.11) 2003 Modelled IHME
0.98 (0.84 - 1.11) 2002 Modelled IHME
0.98 (0.84 - 1.11) 2001 Modelled IHME
0.99 (0.84 - 1.13) 2000 Modelled IHME
1 (0.85 - 1.13) 1999 Modelled IHME
1.01 (0.86 - 1.15) 1998 Modelled IHME
1.03 (0.87 - 1.18) 1997 Modelled IHME
1.04 (0.88 - 1.19) 1996 Modelled IHME
1.05 (0.87 - 1.21) 1995 Modelled IHME
1.04 (0.88 - 1.20) 1994 Modelled IHME
1.04 (0.88 - 1.19) 1993 Modelled IHME
1.04 (0.88 - 1.19) 1992 Modelled IHME
1.03 (0.87 - 1.17) 1991 Modelled IHME
1.01 (0.86 - 1.16) 1990 Modelled IHME
1.94 (0.30 - 10.88) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.08 (0.05 - 0.10) 2019 Modelled IHME
0.08 (0.06 - 0.11) 2018 Modelled IHME
0.08 (0.06 - 0.11) 2017 Modelled IHME
0.08 (0.06 - 0.10) 2016 Modelled IHME
0.08 (0.05 - 0.10) 2015 Modelled IHME
0.08 (0.05 - 0.10) 2014 Modelled IHME
0.08 (0.06 - 0.10) 2013 Modelled IHME
0.08 (0.06 - 0.11) 2012 Modelled IHME
0.08 (0.06 - 0.11) 2011 Modelled IHME
0.09 (0.06 - 0.12) 2010 Modelled IHME
0.1 (0.07 - 0.13) 2009 Modelled IHME
0.12 (0.09 - 0.16) 2008 Modelled IHME
0.16 (0.11 - 0.20) 2007 Modelled IHME
0.19 (0.14 - 0.26) 2006 Modelled IHME
0.23 (0.16 - 0.31) 2005 Modelled IHME
0.29 (0.20 - 0.38) 2004 Modelled IHME
0.35 (0.25 - 0.47) 2003 Modelled IHME
0.43 (0.31 - 0.57) 2002 Modelled IHME
0.49 (0.36 - 0.65) 2001 Modelled IHME
0.52 (0.38 - 0.70) 2000 Modelled IHME
0.54 (0.39 - 0.71) 1999 Modelled IHME
0.56 (0.41 - 0.72) 1998 Modelled IHME
0.57 (0.41 - 0.74) 1997 Modelled IHME
0.58 (0.42 - 0.75) 1996 Modelled IHME
0.58 (0.42 - 0.75) 1995 Modelled IHME
0.58 (0.42 - 0.75) 1994 Modelled IHME
0.58 (0.41 - 0.74) 1993 Modelled IHME
0.57 (0.41 - 0.74) 1992 Modelled IHME
0.55 (0.40 - 0.73) 1991 Modelled IHME
0.54 (0.38 - 0.72) 1990 Modelled IHME
0.2 (0.03 - 1.32) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
23 (16 - 31) 2019 Modelled IHME
23 (16 - 31) 2018 Modelled IHME
23 (16 - 32) 2017 Modelled IHME
23 (16 - 32) 2016 Modelled IHME
24 (17 - 32) 2015 Modelled IHME
24 (17 - 33) 2014 Modelled IHME
25 (18 - 34) 2013 Modelled IHME
25 (18 - 34) 2012 Modelled IHME
26 (18 - 35) 2011 Modelled IHME
26 (18 - 35) 2010 Modelled IHME
26 (18 - 35) 2009 Modelled IHME
26 (18 - 35) 2008 Modelled IHME
26 (18 - 35) 2007 Modelled IHME
26 (19 - 36) 2006 Modelled IHME
26 (19 - 36) 2005 Modelled IHME
26 (19 - 36) 2004 Modelled IHME
26 (19 - 36) 2003 Modelled IHME
27 (19 - 36) 2002 Modelled IHME
27 (19 - 36) 2001 Modelled IHME
27 (19 - 36) 2000 Modelled IHME
27 (19 - 36) 1999 Modelled IHME
27 (19 - 36) 1998 Modelled IHME
27 (19 - 36) 1997 Modelled IHME
27 (19 - 36) 1996 Modelled IHME
27 (19 - 36) 1995 Modelled IHME
27 (19 - 36) 1994 Modelled IHME
27 (19 - 36) 1993 Modelled IHME
27 (19 - 36) 1992 Modelled IHME
26 (19 - 35) 1991 Modelled IHME
26 (19 - 35) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
98 2018 Survey/reported WHO/UNICEF
98 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
98 2015 Survey/reported WHO/UNICEF
98 2014 Survey/reported WHO/UNICEF
98 2013 Survey/reported WHO/UNICEF
99 2012 Survey/reported WHO/UNICEF
97 2011 Survey/reported WHO/UNICEF
95 2010 Survey/reported WHO/UNICEF
93 2009 Survey/reported WHO/UNICEF
92 2008 Survey/reported WHO/UNICEF
90 2007 Survey/reported WHO/UNICEF
88 2006 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
91 2018 Survey/reported WHO/UNICEF
91 2017 Survey/reported WHO/UNICEF
94 2016 Survey/reported WHO/UNICEF
92 2015 Survey/reported WHO/UNICEF
97 2014 Survey/reported WHO/UNICEF
97 2013 Survey/reported WHO/UNICEF
98 2012 Survey/reported WHO/UNICEF
96 2011 Survey/reported WHO/UNICEF
90 2010 Survey/reported WHO/UNICEF
95 2009 Survey/reported WHO/UNICEF
97 2008 Survey/reported WHO/UNICEF
96 2007 Survey/reported WHO/UNICEF
89 2006 Survey/reported WHO/UNICEF
53 2005 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2004
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
Yes
OST in at least one prison
Yes

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1 (0.80 - 1.25) 2019 Modelled IHME
1 (0.81 - 1.25) 2018 Modelled IHME
1 (0.81 - 1.24) 2017 Modelled IHME
0.99 (0.81 - 1.21) 2016 Modelled IHME
0.98 (0.80 - 1.20) 2015 Modelled IHME
0.99 (0.80 - 1.21) 2014 Modelled IHME
0.99 (0.80 - 1.21) 2013 Modelled IHME
0.99 (0.80 - 1.21) 2012 Modelled IHME
0.99 (0.80 - 1.22) 2011 Modelled IHME
1 (0.80 - 1.23) 2010 Modelled IHME
0.99 (0.80 - 1.22) 2009 Modelled IHME
0.99 (0.80 - 1.22) 2008 Modelled IHME
0.98 (0.79 - 1.21) 2007 Modelled IHME
0.98 (0.78 - 1.21) 2006 Modelled IHME
0.97 (0.78 - 1.21) 2005 Modelled IHME
0.97 (0.78 - 1.20) 2004 Modelled IHME
0.97 (0.78 - 1.20) 2003 Modelled IHME
0.97 (0.78 - 1.20) 2002 Modelled IHME
0.97 (0.78 - 1.21) 2001 Modelled IHME
0.97 (0.78 - 1.21) 2000 Modelled IHME
0.97 (0.78 - 1.20) 1999 Modelled IHME
0.97 (0.78 - 1.19) 1998 Modelled IHME
0.96 (0.77 - 1.19) 1997 Modelled IHME
0.96 (0.77 - 1.18) 1996 Modelled IHME
0.96 (0.77 - 1.18) 1995 Modelled IHME
0.95 (0.77 - 1.18) 1994 Modelled IHME
0.95 (0.76 - 1.17) 1993 Modelled IHME
0.94 (0.76 - 1.16) 1992 Modelled IHME
0.94 (0.76 - 1.16) 1991 Modelled IHME
0.94 (0.74 - 1.17) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

People who inject drugs (PWID)
Download
Value (%) Year Type Source
64 (60.80 - 67) 2013 Survey/reported Kiprijanovska S et al, 2013

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
28 (19 - 37) 2019 Modelled IHME
28 (19 - 37) 2018 Modelled IHME
28 (19 - 37) 2017 Modelled IHME
28 (19 - 36) 2016 Modelled IHME
28 (19 - 36) 2015 Modelled IHME
27 (19 - 36) 2014 Modelled IHME
27 (19 - 36) 2013 Modelled IHME
27 (19 - 36) 2012 Modelled IHME
27 (19 - 36) 2011 Modelled IHME
27 (19 - 36) 2010 Modelled IHME
27 (19 - 36) 2009 Modelled IHME
27 (19 - 36) 2008 Modelled IHME
27 (19 - 36) 2007 Modelled IHME
27 (18 - 36) 2006 Modelled IHME
27 (18 - 35) 2005 Modelled IHME
26 (18 - 35) 2004 Modelled IHME
26 (18 - 35) 2003 Modelled IHME
26 (18 - 35) 2002 Modelled IHME
26 (18 - 35) 2001 Modelled IHME
26 (18 - 35) 2000 Modelled IHME
26 (18 - 35) 1999 Modelled IHME
26 (18 - 35) 1998 Modelled IHME
26 (18 - 35) 1997 Modelled IHME
26 (18 - 35) 1996 Modelled IHME
26 (18 - 35) 1995 Modelled IHME
26 (18 - 35) 1994 Modelled IHME
26 (18 - 35) 1993 Modelled IHME
26 (18 - 35) 1992 Modelled IHME
26 (18 - 35) 1991 Modelled IHME
26 (18 - 35) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Year of birth dose introduction
2004
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
Yes
OST in at least one prison
Yes

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.81 (%)
2019
(0.7 - 0.91(%))
IHME
HCV (RNA/cAg+)
1 (%)
2019
(0.8 - 1.25(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
124
2019
(87 - 168)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
139
2019
(97 - 188)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.08 (%)
2019, latest modelled
(0.05 - 0.10(%))
IHME

Prevalence PWID

HCV
64 (%)
2013, survey/surveillance
(60.80 - 67(%))
Kiprijanovska S et al, 2013

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
98 (%)
2018
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines